Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gratus Capital LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 5,000 shares of the medical research company’s stock, valued at approximately $339,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. American […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) – SVB Leerink increased their Q2 2023 earnings per share estimates for Exact Sciences in a research note issued to investors on Tuesday, June 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.50) for the quarter, up […]
Traynor Capital Management Inc. raised its holdings in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 61.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,528 shares of the medical research company’s stock after purchasing an additional 9,706 shares […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $94.34, but opened at $99.00. Exact Sciences shares last traded at $96.19, with a volume of 820,975 shares. Wall Street Analysts Forecast Growth Several research analysts have recently weighed in on […]
Edmonds Duncan Registered Investment Advisors LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,352 shares of the medical research company’s stock, valued at approximately $227,000. A number of […]